In conclusion, we identify SLAMF6 upregulation as a common immune escape mechanism in AML and show that SLAMF6 antibodies targeting this interaction can unleash a strong anticancer T cell response. This evidence concerns the gene SLAMF6 and acute myeloid leukemia.